In addition to GLP-1, it also activates receptors of GIP, another hormone involved in regulating blood sugar and appetite
Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease
The original approved version was discontinued in 2008 for commercial reasons, not safety concerns
You read that great history of Novo Nordisk book, and I'm sure that's the way it paints it
Compounded GLP-1 drugs are a widely known and recent example of compounding
(3) The peptide has been researched for its potential action across diverse functions, including tissue repair, pain perception, gastrointestinal regulation, and tendon, ligament, muscle, and bone cell reparations